question text |
To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton
on 27 January (HL5039), whether the recently approved application by the Human Fertilisation
and Embryology Authority to perform genome editing in human embryos by means of CRISPR-Cas9
will be performed on embryos specifically created for research or only on those considered
to be surplus to infertility treatments; whether that research application included
any application for the creation of embryos; and if not, why the person responsible
requested that reference to surplus embryos should be removed from the research project
title.
|
|